Directory
>
Pamela Esposito
Pamela Esposito
Consultant | Kymera Therapeutics
Cambridge, Massachusetts, United States
Pamela Esposito
Summary
Pamela Esposito is a seasoned executive in the biotechnology and pharmaceutical industries, currently serving as the Chief Business Officer at Replimune. With a strong background in drug development and oncology, she has played pivotal roles in transforming organizations from discovery phases to clinical success. Her leadership at Ra Pharma contributed to its acquisition by UCB for $2.7 billion, showcasing her ability to drive business growth and innovation. Pamela's expertise spans various aspects of life sciences, including oncolytic immunotherapy and peptide drug conjugates. She holds degrees from Tufts University School of Medicine and Dartmouth College, underscoring her strong academic foundation in biochemistry. Known for her strategic vision, she has been instrumental in raising substantial funding for her companies, demonstrating her adeptness in navigating the complexities of the biotech landscape. Pamela's commitment to advancing healthcare solutions is evident in her extensive experience across multiple organizations, including Biovex and Angiochem. Her career reflects a blend of scientific knowledge and business acumen, making her a valuable leader in the sector.
Pamela Esposito
Work Experience
Consultant at
Replimune
April 2024 - Present
Advisor/Consultant/Soul Searcher at
Freelance
April 2024 - Present
Board Member at
Kymera Therapeutics
September 2020 - Present
Board Member at
Accent Therapeutics, Inc.
October 2018 - Present
Chief Business Officer at
Replimune
November 2015 - October 2024
Chief Business Officer at
Ra Pharma
September 2013 - September 2015
Senior Vice President, Strategy & Corporate Development at
AngioChem Inc
September 2011 - September 2013
Vice President, Business Development at
BioVex
March 2010 - January 2011
Director, Business Development & Commercialization at
VION PHARMACEUTICALS (PTY) LTD
January 2008 - December 2009
Head of BD at
Bioduro
January 2006 - January 2006
Associate Director, Business Development and Strategy at
Galenea Corp.
January 2004 - January 2006
Product Manager at
MDS Pharma Services
January 2003 - January 2004
Pamela Esposito
Education
Tufts University School of Medicine
January 1997 - January 2001
Dartmouth College, Bachelor Of Arts (B.A.)
Frequently Asked Questions about Pamela Esposito
What is Pamela Esposito email address?
Pamela Esposito's primary email address is ***************@replimune.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Pamela Esposito work for?
Pamela Esposito is a Consultant at Kymera Therapeutics, a company specializing in Commercial physical research.
Where Pamela Esposito graduated from?
Pamela Esposito holds a degree in from Tufts University School of Medicine.
How can I directly contact Pamela Esposito?
To contact Pamela Esposito directly, you can use the email address ***************@replimune.com. Complete contact information is available upon registration with Muraena.
Who is Pamela Esposito?
Pamela Esposito is a seasoned executive in the biotechnology and pharmaceutical industries, currently serving as the Chief Business Officer at Replimune. With a strong background in drug development and oncology, she has played pivotal roles in transforming organizations from discovery phases to clinical success. Her leadership at Ra Pharma contributed to its acquisition by UCB for $2.7 billion, showcasing her ability to drive business growth and innovation. Pamela's expertise spans various aspects of life sciences, including oncolytic immunotherapy and peptide drug conjugates. She holds degrees from Tufts University School of Medicine and Dartmouth College, underscoring her strong academic foundation in biochemistry. Known for her strategic vision, she has been instrumental in raising substantial funding for her companies, demonstrating her adeptness in navigating the complexities of the biotech landscape. Pamela's commitment to advancing healthcare solutions is evident in her extensive experience across multiple organizations, including Biovex and Angiochem. Her career reflects a blend of scientific knowledge and business acumen, making her a valuable leader in the sector.
Pamela`s contact details
***************@replimune.com
Colleagues
Executive Director
VP Preclinical Development
Chief Financial Officer
Vice President of Finance
Executive Director, Platform Biology
Executive Director, Clinical Data Management
Executive Business Partner to the CEO
Executive Director, Biological Sciences
Founder, President and Chief Executive Officer
Executive Director, Immunology